Evidence map›Paper›PMID 42047923›Full record

ArticleHealth & justice2026

C no more: a prospective single-arm study to evaluate the effectiveness of a nurse and peer-led mobile model of hepatitis C testing and treatment at community corrections offices.

Samara Griffin, Timothy Papaluca, Jacinta A Holmes, Bridget Reid, Anne Craigie, Jane Dicka, Sione Crawford, Amanda Callus, Mark Belzer, Tim Spelman and 5 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Health & justice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Samara GriffinBurnet Institute, Melbourne, Australia. samara.griffin@student.burnet.edu.au.
Timothy PapalucaSt Vincent's Hospital, Melbourne, Australia.
Jacinta A HolmesSt Vincent's Hospital, Melbourne, Australia.
Bridget ReidSt Vincent's Hospital, Melbourne, Australia.
Anne CraigieSt Vincent's Hospital, Melbourne, Australia.
Jane DickaHarm Reduction Victoria, Melbourne, Australia.
Sione CrawfordHarm Reduction Victoria, Melbourne, Australia.
Amanda CallusHarm Reduction Victoria, Melbourne, Australia.
Mark BelzerHarm Reduction Victoria, Melbourne, Australia.
Tim SpelmanBurnet Institute, Melbourne, Australia.
Margaret HellardBurnet Institute, Melbourne, Australia.
Shelley WalkerBurnet Institute, Melbourne, Australia.
Mark StoovéBurnet Institute, Melbourne, Australia.
Alexander J ThompsonSt Vincent's Hospital, Melbourne, Australia.
Rebecca J WinterBurnet Institute, Melbourne, Australia.

Funding

National Health and Medical Research Council GTN 2027497
6 · The paper itself

Abstract

backgroundThe community corrections population in Australia shares similar risk factors for hepatitis C virus (HCV) infection with people incarcerated in prisons, but without access to prison-based testing and treatment. While hepatitis C testing and treatment programs are well established in prison settings in Australia, little attention has been paid to equivalent programs in community corrections settings. C No More is a study to evaluate the acceptability and efficacy of a novel, mobile, nurse and peer-led model of hepatitis C testing and treatment at community corrections offices in Melbourne, Australia.

methodsA clinically equipped van staffed by a hepatitis clinical nurse consultant and peer workers will spend scheduled periods parked adjacent to four community corrections offices in metropolitan Melbourne. People attending community corrections offices will be opportunistically approached by a peer worker and invited to undertake hepatitis C testing. Other individuals in the vicinity of the community corrections office may also be invited to access the service. Following enrolment, study staff will conduct hepatitis C point-of-care testing and clinical assessments in the van. Point-of-care HCV antibody tests will be used for initial screening, and where positive, point-of-care HCV RNA tests performed. Participants with self-reported HCV antibody will be reflexed to RNA testing. RNA positive participants will be assessed for rapid treatment initiation, and prescribed DAA treatment. Treatment dispensation will occur from the van or through a community pharmacy. Participants will be monitored throughout treatment and offered point-of-care HCV RNA testing four or more weeks after treatment completion to confirm sustained virological response (SVR-4 +). The primary outcomes of this study are the proportion of those who are HCV RNA positive who initiate DAA treatment and the acceptability of this model of care. DISCUSSION: This study will provide evidence of acceptability, feasibility, and clinical effectiveness of a nurse and peer-led, mobile model of hepatitis C care at community corrections offices. The outcomes of this study will inform other models of care aiming to provide hepatitis C testing and treatment to individuals involved in the criminal justice system.

trial registrationThis study is registered with the Australian New Zealand Clinical Trials Registry (ACTRN12623001043628). Date of registration: 27/09/2023.

Indexed as

Blood-borne virusesCascade of careCommunity corrections ordersCommunity sentencesCorrectional settingHepatitis C virusMobile servicesNursingPoint-of-care testing

Identifiers

PMID42047923
PMCPMC13182064

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.